{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:50:12Z","timestamp":1791726612972,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cpcardiol.2024.102911","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T06:09:36Z","timestamp":1730268576000},"page":"102911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Thalassemia and iron overload cardiomyopathy: Pathophysiological insights, clinical implications, and management strategies"],"prefix":"10.1016","volume":"50","author":[{"given":"Bagus Aditya","family":"Ansharullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5730-2013","authenticated-orcid":false,"given":"Henry","family":"Sutanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradana Zaky","family":"Romadhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-5-11","article-title":"Beta-thalassemia","volume":"5","author":"Galanello","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"S1","key":"10.1016\/j.cpcardiol.2024.102911_bib0002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ijlh.12527","article-title":"Laboratory diagnosis of thalassemia","volume":"38","author":"Brancaleoni","year":"2016","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0003","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-017-0643-z","article-title":"Thalassemias in South Asia: clinical lessons learnt from Bangladesh","volume":"12","author":"Hossain","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102911_bib0004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","article-title":"Beta-thalassemia","volume":"12","author":"Cao","year":"2010","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0005","doi-asserted-by":"crossref","first-page":"9907","DOI":"10.1038\/s41598-022-14038-8","article-title":"Analysis of rare thalassemia genetic variants based on third-generation sequencing","volume":"12","author":"Peng","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0006","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","article-title":"Iron overload in thalassemia: different organs at different rates","volume":"2017","author":"Taher","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0007","series-title":"StatPearls [Internet]","article-title":"Transfusion iron overload","author":"Rasel","year":"2024"},{"issue":"20","key":"10.1016\/j.cpcardiol.2024.102911_bib0008","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","article-title":"Iron overload cardiomyopathy in clinical practice","volume":"124","author":"Kremastinos","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102911_bib0009","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011726","article-title":"Pathophysiology and clinical manifestations of the \u03b2-thalassemias","volume":"2","author":"Nienhuis","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0010","series-title":"StatPearls [Internet]","article-title":"Alpha thalassemia","author":"Harewood","year":"2024"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0011","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12185-018-2411-9","article-title":"\u03b2-Thalassemia intermedia: a comprehensive overview and novel approaches","volume":"108","author":"Asadov","year":"2018","journal-title":"Int J Hematol"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102911_bib0012","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/10245332.2017.1333246","article-title":"Revisiting beta thalassemia intermedia: past, present, and future prospects","volume":"22","author":"Ben Salah","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0013","series-title":"StatPearls [Internet]","article-title":"Thalassemia","author":"Bajwa","year":"2024"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0014","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1038\/s41598-022-09250-5","article-title":"Significance of borderline HbA2 levels in \u03b2 thalassemia carrier screening","volume":"12","author":"Colaco","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.880752","article-title":"New insights into pathophysiology of \u03b2-thalassemia","author":"Sanchez-Villalobos","year":"2022","journal-title":"Front Med [Internet]"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0016","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-med-043021-032816","article-title":"Hepcidin and iron in health and disease","volume":"74","author":"Nemeth","year":"2022","journal-title":"Annu Rev Med"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102911_bib0017","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/cld.1051","article-title":"Pathology of hepatic iron overload","volume":"17","author":"Salomao","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102911_bib0018","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/0973-6247.83236","article-title":"Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients","volume":"5","author":"Abdulzahra","year":"2011","journal-title":"Asian J Transfus Sci"},{"issue":"13","key":"10.1016\/j.cpcardiol.2024.102911_bib0019","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2010.03.083","article-title":"Iron overload cardiomyopathy, better understanding of an increasing disorder","volume":"56","author":"Gujja","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0020","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JBM.S325096","article-title":"The correlation between iron overload and endocrine function in adult transfusion-dependent beta-thalassemia patients with growth retardation","volume":"12","author":"Atmakusuma","year":"2021","journal-title":"J Blood Med"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0021","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-physiol-022522-102832","article-title":"Iron and the pathophysiology of diabetes","volume":"85","author":"Harrison","year":"2022","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102911_bib0022","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.hoc.2014.04.002","article-title":"Use of magnetic resonance imaging to monitor iron overload","volume":"28","author":"Wood","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0023","article-title":"Severe liver iron concentrations (LIC) in 24 patients with \u03b2-thalassemia major: correlations with serum ferritin, liver enzymes and endocrine complications","volume":"10","author":"Kanbour","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0024","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/JBM.S303703","article-title":"Correlation of serum ferritin and liver iron concentration with transient liver elastography in adult thalassemia intermedia patients with blood transfusion","volume":"12","author":"Atmakusuma","year":"2021","journal-title":"J Blood Med"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102911_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2023.102224","article-title":"Hyperferritinemia and liver iron content determined with MRI: reintroduction of the liver iron index","volume":"47","author":"Moris","year":"2023","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102911_bib0026","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s12098-017-2375-4","article-title":"Serum hepcidin as a diagnostic marker of severe iron overload in beta-thalassemia major","volume":"84","author":"Kaddah","year":"2017","journal-title":"Indian J Pediatr"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102911_bib0027","first-page":"538","article-title":"Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study","volume":"14","author":"Ricchi","year":"2016","journal-title":"Blood Transfusion"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0028","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pbiomolbio.2020.02.008","article-title":"Cardiomyocyte calcium handling in health and disease: insights from in vitro and in silico studies","volume":"157","author":"Sutanto","year":"2020","journal-title":"Prog Biophys Mol Biol"},{"issue":"23","key":"10.1016\/j.cpcardiol.2024.102911_bib0029","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.3390\/jcm10235561","article-title":"The link of pancreatic iron with glucose metabolism and cardiac iron in thalassemia intermedia: a large, multicenter observational study","volume":"10","author":"Meloni","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0030","doi-asserted-by":"crossref","DOI":"10.1097\/CRD.0000000000000622","article-title":"Cardiovascular manifestations of hemochromatosis: a review of pathophysiology, mechanisms, and treatment options","author":"Ahmed","year":"2023","journal-title":"Cardiol Rev"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102911_bib0031","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/joa3.12208","article-title":"Iron overload and arrhythmias: influence of confounding factors","volume":"35","author":"Shizukuda","year":"2019","journal-title":"J Arrhythm"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0032","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12947-022-00291-4","article-title":"Global longitudinal strain for detection of cardiac iron overload in patients with thalassemia: a meta-analysis of observational studies with individual-level participant data","volume":"20","author":"Attar","year":"2022","journal-title":"Cardiovasc Ultrasound"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102911_bib0033","first-page":"555","article-title":"Myocardial longitudinal strain as the first herald of cardiac impairment in very early iron overload state: an echocardiography and biosusceptometry study on beta-thalassemia patients","volume":"11","author":"Barbero","year":"2021","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0034","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/TCRM.S354574","article-title":"Early detection of iron overload cardiomyopathy in transfusion dependent thalassemia patients in Sulaimaniyah City, Iraq","volume":"18","author":"Ahmed","year":"2022","journal-title":"TCRM"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102911_bib0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12574-021-00524-x","article-title":"Advancement of echocardiography for surveillance of iron overload cardiomyopathy: comparison to cardiac magnetic resonance imaging","volume":"19","author":"Zimmerman","year":"2021","journal-title":"J Echocardiogr"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102911_bib0036","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pcad.2011.07.004","article-title":"Assessment of iron overload with T2* magnetic resonance imaging","volume":"54","author":"Anderson","year":"2011","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102911_bib0037","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/jmri.27023","article-title":"Cardiac T2* mapping: techniques and clinical applications","volume":"52","author":"Triadyaksa","year":"2020","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102911_bib0038","doi-asserted-by":"crossref","first-page":"58","DOI":"10.14740\/jmc3240","article-title":"Iron overload cardiomyopathy due to non-classical hereditary hemochromatosis","volume":"10","author":"Hamoudi","year":"2019","journal-title":"J Med Cases"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102911_bib0039","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1540-8175.2011.01584.x","article-title":"Relation between NT-proBNP levels, iron overload, and early stage of myocardial dysfunction in \u03b2-thalassemia major patients","volume":"29","author":"Balkan","year":"2012","journal-title":"Echocardiography"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bcmd.2012.09.002","article-title":"Correlation of NT-proBNP levels and cardiac iron concentration in patients with transfusion-dependent thalassemia major","volume":"50","author":"Delaporta","year":"2013","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102911_bib0041","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/j.ijcard.2008.06.039","article-title":"Abnormal troponin I levels in a thalassemia major patient with high ferritin concentration, permanent atrial fibrillation and without acute coronary syndrome","volume":"138","author":"Patan\u00e8","year":"2010","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0042","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.radcr.2023.10.020","article-title":"Severe iron overload cardiomyopathy manifested as acute myopericarditis: a case report","volume":"19","author":"Kosum","year":"2023","journal-title":"Radiol Case Rep"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0043","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10741-022-10247-5","article-title":"Endomyocardial biopsy in the clinical context: current indications and challenging scenarios","volume":"28","author":"Porcari","year":"2023","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102911_bib0044","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S0828-282X(09)70484-2","article-title":"Do clinical diagnoses correlate with pathological diagnoses in cardiac transplant patients? The importance of endomyocardial biopsy","volume":"25","author":"Luk","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0045","series-title":"StatPearls [Internet]","article-title":"Endomyocardial biopsy","author":"Ahmed","year":"2024"},{"issue":"11","key":"10.1016\/j.cpcardiol.2024.102911_bib0046","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","article-title":"Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment","volume":"16","author":"Murphy","year":"2010","journal-title":"J Cardiac Fail"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102911_bib0047","doi-asserted-by":"crossref","first-page":"560","DOI":"10.5114\/aoms.2017.68729","article-title":"Management of cardiac hemochromatosis","volume":"14","author":"Aronow","year":"2018","journal-title":"Arch Med Sci"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102911_bib0048","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/15353702221076397","article-title":"Iron overload cardiomyopathy: using the latest evidence to inform future applications","volume":"247","author":"Kumfu","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0049","doi-asserted-by":"crossref","first-page":"18132","DOI":"10.1038\/srep18132","article-title":"Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy","volume":"5","author":"Das","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2015.08.017","article-title":"Current and future treatment strategies for iron overload cardiomyopathy","volume":"765","author":"Wongjaikam","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102911_bib0051","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0975-7406.99020","article-title":"Recent advances in gene therapy for thalassemia","volume":"4","author":"Raja","year":"2012","journal-title":"J Pharm Bioallied Sci"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102911_bib0052","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2020.01.002","article-title":"Hematopoietic stem cell transplantation for severe thalassemia patients from haploidentical donors using a novel conditioning regimen","volume":"26","author":"Anurathapan","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cpcardiol.2024.102911_bib0053","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.46.1.319","article-title":"Bone marrow transplantation in thalassemia","volume":"46","author":"Giardini","year":"1995","journal-title":"Annu Rev Med"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102911_bib0054","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1111\/trf.16640","article-title":"The transfusion management of beta thalassemia in the United States","volume":"61","author":"Lal","year":"2021","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/16078454.2020.1856513","article-title":"The association between pre-transfusion hemoglobin levels and thalassemia complications","volume":"26","author":"Wanchaitanawong","year":"2021","journal-title":"Hematology"},{"issue":"24","key":"10.1016\/j.cpcardiol.2024.102911_bib0056","doi-asserted-by":"crossref","first-page":"20441","DOI":"10.1021\/acsomega.2c01833","article-title":"Iron absorption: factors, limitations, and improvement methods","volume":"7","author":"Piskin","year":"2022","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0057","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1749-6632.2010.05591.x","article-title":"Combined iron chelation therapy","volume":"1202","author":"Galanello","year":"2010","journal-title":"Ann New York Acad Sci"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0058","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bcmd.2005.11.002","article-title":"Iron chelation treatment with combined therapy with deferiprone and deferioxamine: a 12-month trial","volume":"36","author":"Kattamis","year":"2006","journal-title":"Blood Cells Mol Dis"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102911_bib0059","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159414","article-title":"Combined iron chelator and antioxidant exerted greater efficacy on cardioprotection than monotherapy in iron-overloaded rats","volume":"11","author":"Wongjaikam","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/10715762.2017.1414208","article-title":"A combination of an iron chelator with an antioxidant exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice","volume":"52","author":"Kumfu","year":"2018","journal-title":"Free Radic Res"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102911_bib0061","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mrm.29021","article-title":"Spectroscopy-based multi-parametric quantification in subjects with liver iron overload at 1.5T and 3T","volume":"87","author":"Simchick","year":"2022","journal-title":"Magn Reson Med"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102911_bib0062","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003230","article-title":"Multiparametric cardiac magnetic resonance survey in children with thalassemia major","volume":"8","author":"Casale","year":"2015","journal-title":"Circul Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102911_bib0063","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1182\/blood-2004-12-4844","article-title":"Hepcidin in iron overload disorders","volume":"105","author":"Papanikolaou","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102911_bib0064","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1007\/s00277-021-04639-0","article-title":"Circulating miRNAs and tissue iron overload in transfusion-dependent \u03b2-thalassemia major: novel predictors and follow-up guide","volume":"100","author":"El-Khazragy","year":"2021","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102911_bib0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102911_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00438-022-01978-z","article-title":"CRISPR\/Cas9, a promising approach for the treatment of \u03b2-thalassemia: a systematic review","volume":"298","author":"Khiabani","year":"2023","journal-title":"Mol Genet Genom"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102911_bib0067","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3324\/haematol.2013.099747","article-title":"Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel","volume":"99","author":"Angelucci","year":"2014","journal-title":"Haematologica"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624005462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624005462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T21:51:01Z","timestamp":1732744261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624005462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0146280624005462"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102911","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thalassemia and iron overload cardiomyopathy: Pathophysiological insights, clinical implications, and management strategies","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102911"}}